Thrombopoietin upregulates the promoter conformation of p53 in a proliferation-independent manner coincident with a decreased expression of Bax: Potential mechanisms for survival enhancing effects

Blood

Volumn 90, Issue 11, 1997, Pages 4394-4402

  Ritchie, Alec ^a   Gotoh, Akihiko ^a   Gaddy, Jay ^a   Braun, Stephen E ^a   Broxmeyer, Hal E ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PROTEIN P53; THROMBOPOIETIN;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; DNA BINDING; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; SUPPRESSOR CELL;

EID: 0030714669     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.11.4394     Document Type: Article

References (60)

1. Koury MJ: Programmed cell death (apoptosis) in hematopoiesis. Exp Hematol 20:391, 1992
2. Tewari M, Dixit VM: Fas- and TNF-induced apoptosis is inhibited by the poxvirus crmA gene product. J Biol Chem 270:3255, 1995
3. Crompton T: IL-3-dependent cells die by apoptosis on removal of their growth factor. Growth Factors 4:109, 1991
4. Rodriguez-Tarduchy G, Collins M, Lopez-Rivas A: Regulation of apoptosis in interleukin-3-dependent hematopoietic cells by interleukin-3 and calcium ionophores. EMBO J 9:2997, 1990
5. Williams GT, Smith CA, Spooner E, Dexter TM, Taylor DR: Haematopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343:76, 1990
6. Caceres-Cortes J, Rajotte D, Dumouchel J, Haddad P, Hoang T: Product of the steel locus suppresses apoptosis in hematopoietic cells. J Biol Chem 269:12084, 1994
7. Horie M, Broxmeyer HE: The combination of steel factor and GM-CSF blocks apoptosis induced by retinoic acid and upregulates AP-1 in a human growth factor-dependent cell line. Exp Hematol 23:168, 1995
8. Ritchie A, Raj S, Broxmeyer HE: Thrombopoietin behaves as a survival factor and suppresses apoptosis in a human growth factor dependent cell line M07e. Stem Cells 14:330, 1996
9. Williams GT: Apoptosis. Oxford, UK, Oxford University Press, 1991, p 69
10. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M: Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 352:345, 1991
11. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304, 1991
12. Livingstone LR, White R, Sprouse J, Livanous E, Jacks T, Tolsty TD: Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923, 1992
13. Kastan MB, Zhan Q, El-Diery WS, Carrier F, Jacks T, Walsh WV, Plunkett BV, Vogelstein B, Fornace AJ: A mammalian cell cycle checkpoint utilizing p53 and gadd45 is defective in ataxiatelangiectasia. Cell 71:587, 1992
14. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer E, Kinzler KW, Vogelstein B: WAF1, a potent mediator of p53 tumor suppression. Cell 75:817, 1993
15. Miyahsita T, Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293, 1995
16. Zhu Y-M, Bradbury DA, Russell NH: Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells. Br J Cancer 69:468, 1994
17. Gottlieb E, Haffner R, von Ruden T, Wagner EF, Oren M: Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J 13:1368, 1994
18. Blandino G, Scardigli R, Rizzo MG, Crescenzi M, Soddu S, Sacchi A: Wild-type p53 modulates apoptosis of normal IL-3 deprived hematopoietic cells. Oncogene 10:731, 1995
19. Johnson P, Chung S, Benchimol S: Growth suppression of friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erylhropoietin. Mol Cell Biol 13:1456, 1993
20. Abrahamson JLA, Lee JM, Bernstein A: Regulation of p53-mediated apoptosis and cell cycle arrest by steel factor. Mol Cell Biol 15:6953, 1995
21. Ball RK, Siegle B, Quellhorst S, Brander G, Braun DG: Monoclonal antibodies against simian virus 40 nuclear large T antigen: Epitope mapping papova virus cross-reaction and cell surface staining. EMBO J 3:1485, 1984
22. Milner J, Watson JV: Addition of fresh medium induces cell cycle and conformational changes in p53, a tumour suppressor protein. Oncogene 5:1683, 1990
23. Gannon JV, Greaves R, Iggo R, Lane DP: Activating mutations in p53 produce a common conformational effect: A monoclonal antibody specific for mutant form. EMBO J 9:1595, 1990
24. Milner J: A conformational hypothesis for the suppressor and promoter functions of p53 in cell growth control and in cancer. Proc R Soc Lond 245:139, 1991
25. Zhang W, Hu G, Estey E, Hester J, Deisseroth A: Altered conformation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cells. Oncogene 7:1645, 1992
26. Zhu Y-M, Bradbury DA, Russell NH: Expression of different conformations of p53 in the blast cells of acute myeloblastic leukaemia is related to in vitro growth characteristics. Br J Cancer 68:851, 1993
27. Rivas CI, Wisniewski D, Strife A, Ferez A, Lambek C, Bruno S, Darzynkiewicz Z, Clarkson B: Constituative expression of p53 protein in enriched normal human marrow blast cell populations. Blood 79:1982, 1992
28. Boise LH, Gottschalk AR, Quintans J, Thompson CB: Bcl-2 and bcl-2-related proteins in apoptosis regulation. Curr Top Microbiol Immunol 200:107, 1995
29. Kumar S, Kinoshita M, Noda M, Copeland NG, Jenkins NA: Induction of apoptosis by the mouse Nedd2 gene which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme. Genes Develop 8:1613, 1994
30. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Linsten T, Turka LA, Mao X, Nunez G, Thompson CB: Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597, 1993
31. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homologue bax that accelerates apoptosis. Cell 74:609, 1993
32. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799, 1994
33. Kaushansky K: Thrombopoietin: Basic biology clinical promise. Int J Hematol 62:7, 1995
34. Gewirtz AM: Megakaryocytopoiesis: The state of the art. Thrombosis Haemostasis 74:204, 1995
35. Broudy VC, Lin NL, Kaushansky K: Thrombopoietin (c-mpl ligand) acts synergystically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony formation and increase megakaryocyte ploidy in vitro. Blood 85:1719, 1995
36. Carver-Morre K, Broxmeyer HE, Luoh SM, Cooper S, Peng J, Burstein S, Moore MW, de Sauvage FJ: Low levels of erythroid and myeloid progenitors in Tpo and c-mpl deficient mice. Blood 88:803, 1996
37. Vadhan-Raj S, Murray LJ, Buesco-Ramos C, Patel S, Reddy SP, Hoofs WK, Johnston T, Papadopolous NE, Hittelman WN, Tang TA, Paton VE, Cohen RL, Hellman SD, Benjamin RS, Broxmeyer HE: Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in cancer patients. Ann Intern Med 126:673, 1997
38. Avanzi G, Lista P, Giovinazzo B, Miniero R, Saglio G, Benetton G, Coda R, Cattoretti G, Pegoraro L: Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic feastures. Br J Hematol 69:359, 1988
39. Avanzi G, Brizzi M, Giannotti J, Ciarletta A, Yang YC, Pegoraro L, Clark SC: M-07e human leukemic factor-dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM-CSF and IL-3. J Cell Physiol 145:458, 1990
40. Hendrie P, Miyazawa K, Yang YC, Langefeld CD, Broxmeyer HE: Mast cell growth factor (c-kit ligand) enhances cytokine stimulation of proliferation of the human factor dependent cell line M07e. Exp Hematol 19:1031, 1991
41. Miyazawa K, Hendrie P, Mantel C, Wood K, Ashman LK, Broxmeyer HE: Comparative analysis of signaling pathways between mast cell growth factor (c-kit) and granulocyte-macrophage colony stimulating factor in a human factor-dependent myeloid cell line involves phosphorylation of raf-1 GTPase-activating protein and mitogen-activated protein kinase. Exp Hematol 19:1110, 1991
42. Bi S, Lanza F, Goldman JM: The abnormal p53 proteins expressed in CML cell lines are non-functional. Leukemia 7:1840, 1993
43. Lanza F, Bi S, Moretti S, Castoldi G, Goldman JM: Modulation of cell kinetics and cell cycle status by treating with CD34+ chronic myeloid leukaemia cells with p53 antisense phosphorothioate oligonucleotides. Br J Hematol 90:8, 1995
44. fak) and paxillin. Blood 89:1547, 1997
45. Allfrey VC, Littau VC, Mirsky AE: Methods for the purification of thymus nuclei and their application to studies of nuclear protein synthesis. J Cell Biol 21:213, 1964
46. Hainaut P, Milner J: Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res 53:4469, 1993
47. Gotoh A, Takahira H, Mantel C, Litz-Jackson S, Boswell HS, Broxmeyer HE: Steel factor induces serine phosphorylation of stat3 in human growth factor-dependent myeloid cell lines. Blood 88:138, 1996
48. 135. J Mol Biol 216:481, 1990
49. Oren M, Maltzman W, Levine AJ: Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol Cell Biol 1:101, 1981
50. Momand J, Zambetti GP, Olson DC, George D, Levine AJ: The mdm2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237, 1992
51. Gannon JV, Lane DP: Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport. Nature 349:802, 1991
52. Zerrahn J, Deppert W, Weidemann D, Patschinsky T, Richards F, Milner J: Correlation between the conformational phenotype of p53 and its subcellular location. Oncogene 7:1371, 1992
53. Shaulsky G, Goldfinger N, Tosky MS, Levine AJ, Rotter V: Nuclear localization is essential for the activity of p53 protein. Oncogene 6:2055, 1991
54. Baffy G, Miyashita T, Williamson JR, Reed JC: Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. J Biol Chem 268:6511, 1993
55. Rinaudo MS, Su K, Falk LA, Halder S, Mufson RA: Human interleukin-3 receptor modulates bcl-2 mRNA and protein levels through protein kinase C in TF-1 cells. Blood 86:80, 1995
56. Shaulsky G, Ben-Ze'ev A, Rotter V: Subcellular distribution of the p53 protein during the cell cycle of balb/c 3T3 cells. Oncogene 5:1710, 1990
57. Zhu H, Fearnhead HO, Cohen GM: An ICE-like protease is a common mediator of apoptosis induced by diverse stimuli in human monocytic THP-1 cells. FEBS Lett 374:303, 1995
58. de Vente JE, Kukoly CA, Bryant WO, Posekany KJ, Chen J, Fletcher DJ, Parker PJ, Pettit GJ, Lozano G, Cook PP, Ways DK: Phorbol esters induce death in MCF-7 breast cancer cells with altered expression of protein kinase C isoforms role for p53-independent induction of gadd45 in initiating death. J Clin Invest 96:1874, 1995
59. Zeng YX, EI-Deiry WS: Regulation of p21waf1/cip1 expression by p53-independent pathways. Oncogene 12:1557, 1996
60. Cross SM, Sanchez CA, Morgan CA, Schinke MK, Ramel S, Idzerda RL, Raskind WH, Reid BJ: A p53-dependent mouse spindle checkpoint. Science 267:1353, 1995